Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas

Journal of Drug Targeting

Volumn 19, Issue 6, 2011, Pages 427-433

  Jones, Alphia K ^a,e   Bejugam, Naveen K ^a,b   Nettey, Henry ^a,c   Addo, Richard ^a,d   D'souza, Martin J ^a  

^a MERCER UNIVERSITY   (United States)

^b SRI INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d SHENANDOAH UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

doxorubicin; melanoma tumor cells; Microspheres; multidrug resistance; spray drying

Indexed keywords

ALBUMIN; DOXORUBICIN; MICROSPHERE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG UPTAKE; IN VITRO STUDY; MELANOMA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SPRAY DRYING; ZETA POTENTIAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG COMPOUNDING; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; MELANOMA; MICE; MICROSPHERES; PARTICLE SIZE; RATS; SERUM ALBUMIN, BOVINE; SOLUBILITY; SURFACE PROPERTIES;

EID: 79958805081     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.504270     Document Type: Article

References (20)

1. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release, 79, 29-40. (Pubitemid 34164159)
2. Akhavein N, Oettinger CW, Gayakwad SG, Addo RT, Bejugam NK, Bauer JD, Do D, Pollock SH, D'souza MJ. (2009). Treatment of adjuvant arthritis using microencapsulated antisense NF-kappaB oligonucleotides. J Microencapsul, 26, 223-234.
3. Arifin DY, Lee LY, Wang CH. (2006). Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev, 58, 1274-1325.
4. Banga AK. (2006). Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, 2nd edn. Boca Raton, FL: CRC/Taylor & Francis.
5. Basarkar A, Devineni D, Palaniappan R, Singh J. (2007). Preparation, characterization, cytotoxicity and transfection efficiency of poly(DLlactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm, 343, 247-254. (Pubitemid 47334869)
6. Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25, 577-583.
7. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13, 123-133. (Pubitemid 32288781)
8. Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D'Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. J Microencapsul, 26, 692-700.
9. Higuchi T. (1960). Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem, 11, 85-97.
10. Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50, 874-875.
11. Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52, 1145-1149.
12. Hunter RJ. (1981). Zeta Potential in Colloid Science: Principles and Applications. London; New York: Academic Press.
13. Jin Z. (2004). Evaluation of tumor suppression after treatment with microencapsulated lipo-polysaccharides. In: Department of Pharmaceutical Sciences. Atlanta: Mercer University.
14. Lehne G. (2000). P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets, 1, 85-99.
15. Liu Z, Ballinger JR, Rauth AM, Bendayan R, Wu XY. (2003). Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J Pharm Pharmacol, 55, 1063-1073. (Pubitemid 36998646)
16. Mathiowitz E, Jacob JS, Jong YS, Carino GP, Chickering DE, Chaturvedi P, Santos CA, Vijayaraghavan K, Montgomery S, Bassett M, Morrell C. (1997). Biologically erodable microspheres as potential oral drug delivery systems. Nature, 386, 410-414. (Pubitemid 27154483)
17. Okada H, Toguchi H. (1995). Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst, 12, 1-99.
18. Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D'Souza MJ. (2009). Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target, 17, 553-560.
19. Zheng JH, Chen CT, Au JL, Wientjes MG. (2001). Time-and concentration-dependent penetration of doxorubicin in prostate tumors. AAPS PharmSci, 3, E15
20. Lehne G. (2000). P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr Drug Targets, 1, 85-99.